Biotech startups in Zürich, Switzerland
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Cutiss | Zürich | Series C | $38.8M | 2025-09-10 |
| TOLREMO therapeutics | Zürich | Series A | $37.9M | 2023-09-20 |
| Navignostics | Zürich | Seed | $7.6M | 2022-11-09 |
| CellX Biosolutions | Zürich | Pre-seed | $1.9M | 2025-02-25 |
| metaLead Therapeutics | Zürich | Seed | $1.2M | 2025-05-06 |
| Cube RM | Zürich | Series A | $8.0M | 2021-12-14 |
| Invasight | Zürich | Seed | $4.6M | 2022-06-07 |
| Nerai Bio | Zürich | Seed | $170K | 2024-11-11 |
8 rows of the CSV in 5 of its 18 columns.
- The 25 biotech startups in Zürich, Switzerland have raised $147.3M in total.
- 3 of them closed their most recent round in the last 12 months, $5.4M combined.
- The largest of those rounds is Prevision Medicine's $5.4M seed round, dated September 2026.
- Venture Kick is an investor in 9 of them, more than any other fund.
- Health care is the most common other sector, with 19 companies (76%).
- 42% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 1 to 10 employees (64% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
5 of 25| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Cutiss | Cutiss is a life science company that produces regenerative medicine and engineers skin tissue. | Biotech | Series C | $38.8M | 2025-09-10 | $94.6M | Innosuisse | 11 to 50 | 2017 |
| CellX Biosolutions | CellX Biosolutions provides sustainable treatment of chemical waste. | Biotech | Pre-seed | $1.9M | 2025-02-25 | $2.1M | Venture Kick, MassChallenge Switzerland | 1 to 10 | 2024 |
| TOLREMO therapeutics | TOLREMO therapeutics develops small molecules that target drug resistance pathways in cancer therapy. | Biotech | Series A | $37.9M | 2023-09-20 | Altos Ventures, redalpine, BioMedPartners +1 | 11 to 50 | 2017 | |
| dacadoo | dacadoo offers digital lifestyle solutions through mobile apps from its base in Switzerland. | Biotech | Series C | $71.1M | 2019-12-13 | Samsung Ventures | 51 to 100 | 2010 | |
| Inositec | Inositec is a biotech company developing a treatment for soft tissue calcification disorders. | Biotech | Seed | $1.4M | 2016-10-26 | $1.4M | Venture Kick, VentureOut, VI Partners | 1 to 10 | 2015 |
Table 1. Biotech startups in Zürich, Switzerland: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 25.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Venture Kick | Startup incubator | Schlieren, Switzerland | 9 | 36% | ||
| 2 | redalpine | Venture capital firm | Zürich, Switzerland | 2 | 8% | ||
| 3 | Verve Ventures | Venture capital firm | Zug, Switzerland | 2 | 8% | ||
| 4 | Innosuisse | Government investment office | Berne, Switzerland | 1 | 4% | ||
| 5 | Samsung Ventures | Corporate venture arm | Seoul, South Korea | 1 | 4% | ||
| 6 | Altos Ventures | Venture capital firm | Burlingame, United States | 1 | 4% | ||
| 7 | BioMedPartners | Venture capital firm | Basel, Switzerland | 1 | 4% | ||
| 8 | Pierre Fabre Invest | Corporate venture arm | Castres, France | 1 | 4% | ||
| 9 | Think.Health | Venture capital firm | Fürstenfeldbruck, Germany | 1 | 4% | ||
| 10 | Ventura BioMed Investors | Venture capital firm | Munich, Germany | 1 | 4% | ||
| 11 | MassChallenge Switzerland | Startup accelerator | Renens, Switzerland | 1 | 4% | ||
| 12 | Marathon Venture Capital | Venture capital firm | Athens, Greece | 1 | 4% | ||
| 13 | Runa Capital | Venture capital firm | Luxembourg | 1 | 4% | ||
| 14 | Wille Finance | Family office | Zürich, Switzerland | 1 | 4% | ||
| 15 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 1 | 4% |
Table 2. Biotech startups in Zürich, Switzerland: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 19 | 76% | $116.8M |
| Software | 8 | 32% | $4.5M |
| Artificial intelligence | 4 | 16% | $170K |
| Fintech | 1 | 4% | |
| Hardware | 1 | 4% | |
| Commerce | 1 | 4% |
Table 3. Biotech startups in Zürich, Switzerland by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 4 | 16% | $184K |
| Seed | 15 | 60% | $3.4M |
| Series A | 3 | 12% | $37.9M |
| Series B | 1 | 4% | $4.4M |
| Series C | 2 | 8% | $71.1M |
Table 4. Biotech startups in Zürich, Switzerland by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 2 | 67% | $5.4M |
| April 2026 | 1 | 33% |
Table 5. Biotech startups in Zürich, Switzerland: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 3 | 12% | $5.4M |
| 2025 | 6 | 24% | $70.2M |
| 2024 | 3 | 12% | $3.3M |
| 2023 | 1 | 4% | $37.9M |
| 2022 | 2 | 8% | $12.2M |
| 2021 | 2 | 8% | $8.0M |
Table 6. Biotech startups in Zürich, Switzerland by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 6 | 25% |
| 2020 to 2022 | 4 | 17% |
| 2015 to 2019 | 11 | 46% |
| 2010 to 2014 | 1 | 4% |
| Before 2010 | 2 | 8% |
Table 7. Biotech startups in Zürich, Switzerland by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 16 | 64% |
| 11 to 50 | 7 | 28% |
| 51 to 100 | 2 | 8% |
Table 8. Biotech startups in Zürich, Switzerland by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Zürich, Switzerland. On 16 November 2026 that is 25 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 5 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 25 rows: 7 have no round amount, 0 no city and 8 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Zürich, Switzerland are on the list?
- 25, in the file dated 16 November 2026. 3 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 25 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.